Natalya Risinskaya

13PUBLICATIONS
30CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 27, 2026
Copy-Number Alterations and Copy-Neutral Loss of Heterozygosity in Adult T-ALL: A Descriptive Study in Relation to Day +70 MRD.

|Sep 13, 2025
Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma.

Maiia Soloveva, Maksim Solovev, Igor Yakutik

|Aug 14, 2025
PSG and Other Candidate Genes as Potential Biomarkers of Therapy Resistance in B-ALL: Insights from Chromosomal Microarray Analysis and Machine Learning.

Valeriya Surimova, Natalya Risinskaya, Ekaterina Kotova

|Jul 29, 2025
Missense Mutations in the KAT Domain of CREBBP Gene in Patients with Follicular Lymphoma: Implications for Differential Diagnosis and Prognosis.

Anna Smolianinova, Ivan Bolshakov, Yulia Sidorova

|Oct 16, 2024
Biallelic Loss of 7q34 (TRB) and 9p21.3 (CDKN2A/2B) in Adult Ph-Negative Acute T-Lymphoblastic Leukemia.

Natalya Risinskaya, Abdulpatakh Abdulpatakhov, Yulia Chabaeva

|Sep 14, 2024
Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma.

Maiia Soloveva, Maksim Solovev, Natalya Risinskaya

Pageof 3

Frequent Collaborators

9 joint publications

Andrey Sudarikov

5 joint publications

Yulia Chabaeva

4 joint publications

Tatiana Obukhova

3 joint publications

Yana Kozhevnikova